National Academies Press: OpenBook
« Previous: Glossary
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2009. Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12535.
×
Page 111
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2009. Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12535.
×
Page 112
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2009. Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12535.
×
Page 113
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2009. Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12535.
×
Page 114
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2009. Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12535.
×
Page 115
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2009. Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12535.
×
Page 116

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendix A Workshop Agenda National Cancer Policy Forum Workshop on Multi-Center Phase III Clinical Trials and NCI Cooperative Groups The Keck Center of The National Academies Room 100 500 Fifth Street, NW Washington, DC 20001 Agenda July 1–2, 2008 Day 1: July 1, 2008 Welcome and Opening Remarks 8:00 am – 8:30 am John Niederhuber, NCI Session 1: Organization of the nci clinical trials system and operation of Phase iii clinical trials 8:30 am – 12:45 pm ÿ Session 1A: Organization of the nci clinical trial system trials system 8:30 am – 11:00 am Moderator: David Parkinson, Nodality, Inc. Jeffrey S. Abrams, NCI “NCI’s Clinical Trials Program” 111

112 MULTI-CENTER PHASE III CLINICAL TRIALS Jan C. Buckner, Mayo Clinic  “Mayo Clinic and North Central Cancer Treatment Group: An Academic-Community Partnership” Walter J. Curran, Jr., Winship Cancer Institute, Emory University “Organization of the Radiation Therapy Oncology Group” David M. Dilts, Vanderbilt University  “Activating & Opening Oncology Clinical Trials: Process & Timing Analysis” Richard L. Schilsky, University of Chicago, Cancer & Leukemia Group B “Rising to the Challenge of Rapid Protocol Activation” Break 11:00 am – 11:15 am ÿ Session 1B: operation of phase III clinical trials 11:15 am – 12:45 pm Moderator: Richard L. Schilsky, University of Chicago Robert M. Califf, Duke University “Organization of Multi-Center Trials: Are Oncopolitics Different than Other Clinical Research Politics” Renzo Canetta, Bristol–Myers Squibb “Industry-Sponsored Multi-Center Trials” Alan Keller, Cancer Care Associates “Multi-Center Clinical Trials in the Community: Models and Methods: What Works, What Doesn’t, and Why” Lunch Break 12:45 pm – 1:30 pm Session 2: Patient recruitment and physician participation 1:30 pm – 5:15 pm ÿ Session 2A: panel on academic challenges 1:30 pm – 3:00 pm Moderator: John Mendelsohn, M. D. Anderson Cancer Center

APPENDIX A 113 Academic Panel: Laurence H. Baker, Southwest Oncology Group and The University of Michigan  “Southwest Oncology Group View of Barriers to Cooperative Group Accrual” Gordon R. Bernard, Vanderbilt University “Cancer Clinical Research: The Institutional Perspective” Michael A. Caligiuri, The Ohio State University Comprehensive Cancer Center – James Cancer Hospital “Access to Clinical Trials: Impeding the Insured” Allen S. Lichter, American Society of Clinical Oncology  “The Pitfalls of Career Advancement for the Clinical Trialists: A Decanal Perspective” Panel Discussion Break 3:00 pm – 3:15 pm ÿ Session 2B: other perspectives 3:15 pm – 5:15 pm Moderator: Hal Moses, Vanderbilt University Stephen S. Grubbs, Delaware Christiana Care CCOP “CCOP Clinical Trials Contributions and Challenges” John E. Feldmann, Moses Cone Regional Cancer Center “Community Cancer Centers: The Crisis in Clinical Trials” Richard Kaplan, National Cancer Research Network, United Kingdom  “Publicly Funded Cooperative Groups Working with Industry” Deborah Collyar, Patient Advocates in Research “Connecting Clinical Trials to People” Adjourn Day 1 5:15 pm

114 MULTI-CENTER PHASE III CLINICAL TRIALS Day 2: July 2, 2008 Welcome and Opening Remarks 8:00 am – 8:15 am John Mendelsohn, M. D. Anderson Cancer Center Session 3: Data collection standards to establish safety and efficacy 8:15 am – 10:00 am Moderator: Renzo Canetta, Bristol–Myers Squibb James H. Doroshow, National Institutes of Health “NIH Perspective” Gwendolyn Fyfe, Genentech “A Perspective on How to Quickly Define Data Standards” Robert L. Comis, Coalition of National Cancer Cooperative Groups  “The Role of Cooperative Groups in Establishing Safety and Efficacy” Panel Discussion: James Doroshow, Gwendolyn Fyfe, Robert Comis, and Richard Pazdur, FDA Break 10:00 am – 10:15 am Session 4: Costs/Payments 10:15 am – 12:45 pm Moderator: Robert L. Comis, Coalition of National Cancer Cooperative Groups Al B. Benson III, Robert H. Lurie Comprehensive Cancer Center “Cooperative Groups and Cost Analysis” Marcy Waldinger, University of Michigan Comprehensive Cancer Center “Cost-out” Maurie Markman, M. D. Anderson Cancer Center  “Regulatory Compliance: Impact on Patients and Academic Institutions Conducting Clinical Research”

APPENDIX A 115 Leslye K. Fitterman, CMS “CMS Clinical Trial Policy” Lee N. Newcomer, UnitedHealthcare “An Insurer’s View: Paying for Clinical Trials” Wrap-up 12:45 pm – 1:00 pm John Mendelsohn and Hal Moses Adjourn Day 2 1:00 pm

Next: Appendix B: Workshop Speakers »
Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary Get This Book
×
Buy Paperback | $46.00 Buy Ebook | $36.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The NCI-sponsored cooperative groups have made important contributions to improving treatment for many types of cancer, including breast, ovarian, colorectal, and childhood cancers. Cooperative group research has been instrumental in establishing innovative treatments that improve outcomes and quality of life. Despite these successes, the Cooperative Group Program has faced a number of challenges that threaten its effectiveness.

To address this problem, the National Cancer Policy Forum (NCPF) convened a workshop titled "Multi-Center Phase III Clinical Trials and NCI Cooperative Groups" in Washington, DC, on July 1-2, 2008. The purpose of the workshop was to outline the challenges that the public clinical cancer research enterprise faces, and to identify possible solutions to these challenges.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!